GENEVA, May 5 -- MORPHOSYS AG (Semmelweisstr. 782152 Planegg) filed a patent application (PCT/EP2024/078149) for "BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20" on Oct 07, 2024. With publication no. WO/2025/087681, the details related to the patent application was published on May 01, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): HEITMULLER, Christina (Erikastr. 15a82515 Wolfratshausen), SCHAADT, Eveline (St.-Stephan-Weg 2682041 Oberhaching), FELDERER, Karin (Leutstettener Str. 56b81477 Munchen)
Abstract:
The present invention provides bispecific antibodies comprising a first and a second ...